Publications by authors named "Terrence Fisher"

Claim this Profile
P
Pepinemab: a SEMA4D antagonist for treatment of Huntington's and other neurodegenerative diseases.
Andrew Feigin, Elizabeth E Evans, Terrence L Fisher, Maurice Zauderer

Expert Opin Investig Drugs· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614).
Emily Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Terrence Fisher

Pediatr Blood Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial.
Andrew Feigin, Elizabeth E Evans, Terrence L Fisher, John E Leonard, Ernest S Smith

Nat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial.
Andrew Feigin, Elizabeth E Evans, Terrence L Fisher, John E Leonard, Ernest S Smith

Nat Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity.
Elizabeth E Evans, Vikas Mishra, Crystal Mallow, Elaine M Gersz, Leslie Balch, Terrence L Fisher

J Neuroinflammation· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer.
Michael R Shafique, Terrence L Fisher, Elizabeth E Evans, John E Leonard, Desa Rae E Pastore

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trial.
Christopher LaGanke, Lawrence Samkoff, Keith Edwards, Lily Jung Henson, Pavle Repovic, Terrence L Fisher

Neurol Neuroimmunol Neuroinflamm· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and preclinical characterization of an antibody specific for SEMA4D.
Terrence L Fisher, Christine A Reilly, Laurie A Winter, Tracy Pandina, Alan Jonason

MAbs· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saturation monitoring of VX15/2503, a novel semaphorin 4D-specific antibody, in clinical trials.
Terrence L Fisher, Jennifer Seils, Christine Reilly, Virginia Litwin, Lisa Green

Cytometry B Clin Cytom· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors.
Amita Patnaik, Glen J Weiss, John E Leonard, Drew Warren Rasco, Jasgit C Sachdev, Terrence L Fisher

Clin Cancer Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of exercise and diet on olfactory capability in detection dogs.
Craig T Angle, Joseph J Wakshlag, Robert L Gillette, Todd Steury, Pamela Haney, Terrence Fisher

J Nutr Sci· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
Elizabeth E Evans, Alan S Jonason, Holm Bussler, Sebold Torno, Janaki Veeraraghavan, Terrence L Fisher

Cancer Immunol Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody.
John E Leonard, Terrence L Fisher, Laurie A Winter, Chad A Cornelius, Christine Reilly

Mol Cancer Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
Ernest S Smith, Alan Jonason, Christine Reilly, Janaki Veeraraghavan, Terrence Fisher

Neurobiol Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
Terrence L Fisher, MaryAnn Nocera, Richard A Willis, Michael J Turner, C Siddiq Abdul Alim

Prostate· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis